|
|
Article: Companies to work together to identify new lead compounds against targets.
- Article from:
- Drug Week
- Article date:
- February 28, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 FEB 28 - (NewsRx.com & NewsRx.net) -- Pharmacopeia, Inc., (PCOP) announced the signing of a new collaboration agreement with Novartis, AG, effective January 9, 2003.
Under the terms of this new agreement, the companies will collaborate to identify new lead compounds against multiple drug targets from Novartis' discovery programs.
"The collaboration with Pharmacopeia will support our effort in this rapidly growing area of lead finding. We are ...